Troglitazone's effect on lipoprotein(a) levels.
Ovalle
F
F
Bell
D S
DS
D002839:Chromans / Q000627:therapeutic use*; D003924:Diabetes Mellitus, Type 2 / Q000097:blood* / Q000188:drug therapy*; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D007004:Hypoglycemic Agents / Q000627:therapeutic use*; D017270:Lipoprotein(a) / Q000097:blood* / Q000187:drug effects; D008297:Male; D008875:Middle Aged; D013844:Thiazoles / Q000627:therapeutic use*; D045162:Thiazolidinediones; D013997:Time Factors; D000077288:Troglitazone
D002839:Chromans; D007004:Hypoglycemic Agents; D017270:Lipoprotein(a); D013844:Thiazoles; D045162:Thiazolidinediones; D000077288:Troglitazone